Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 7
1976 15
1977 19
1978 16
1979 43
1980 47
1981 54
1982 69
1983 61
1984 57
1985 71
1986 59
1987 67
1988 65
1989 57
1990 74
1991 73
1992 97
1993 85
1994 90
1995 89
1996 101
1997 83
1998 75
1999 100
2000 108
2001 142
2002 130
2003 135
2004 127
2005 154
2006 137
2007 179
2008 148
2009 179
2010 172
2011 173
2012 160
2013 178
2014 164
2015 135
2016 140
2017 151
2018 142
2019 60
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

4,183 results
Results by year
Filters applied: . Clear all
Page 1
Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy
Mock CM and Schwetschenau KH. Am J Health Syst Pharm 2012 - Review. PMID 22180549
No adverse events related to levocarnitine therapy were reported in any of the literature reviewed. Prospective trials are needed to further support the efficacy and safety of levocarnitine in the treatment of VHE. ...
No adverse events related to levocarnitine therapy were reported in any of the literature reviewed. Prospective trials are needed to …
Drug-Induced Liver Injury
Almario EE, et al. Biomed Res Int 2017. PMID 28164116 Free PMC article.
Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug
Tomson T, et al. Lancet Neurol 2016 - Review. PMID 26655849
However, during the past few years increasing evidence has accumulated that intake of valproic acid during pregnancy is associated with a significant risk of dose-dependent teratogenic effects and impaired postnatal cognitive development in children. ...
However, during the past few years increasing evidence has accumulated that intake of valproic acid during pregnancy is associated with a si …
Hematologic toxicity of sodium valproate
Acharya S and Bussel JB. J Pediatr Hematol Oncol 2000 - Review. PMID 10695824
Potential adverse effects such as thrombocytopenia and leukopenia are easily detected by laboratory monitoring, which should be continued indefinitely at least on a quarterly basis. ...
Potential adverse effects such as thrombocytopenia and leukopenia are easily detected by laboratory monitoring, which should b …
Valproate in Pregnancy: Recent Research and Regulatory Responses
Andrade C. J Clin Psychiatry 2018 - Review. PMID 29873961 Free article.
Although untreated epilepsy is itself associated with many adverse gestational and neonatal outcomes, confounding by indication is an unlikely explanation for the adverse outcomes observed with valproate. This is because of the range of the adverse outcomes, the magnitude of the risks, the dose-dependent nature of the risks, the consistency of findings across studies, the specificity of outcomes for valproate exposure, and the greater risks with valproate relative to other AEDs. ...
Although untreated epilepsy is itself associated with many adverse gestational and neonatal outcomes, confounding by indication is an …
4,183 results
Jump to page
Feedback